News

BeOne Medicines has secured approval from the European Commission (EC) for Tevimbra (tislelizumab) to be used along with ...
The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...
In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...
(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission has approved TEVIMBRA ® (tislelizumab), in combination with gemcitabine and cisplatin, ...
In an interview, Aditya Shreenivas, MD, MS, discussed the approval of penpulimab in nasopharyngeal carcinoma and the study that supports it. In April 2025, the FDA granted approval to the combination ...
ABSTRACT: Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor with a unique geographical distribution, predominantly prevalent in East Africa and Asia. Despite advances in understanding its ...
Abstract Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor with a unique geographical distribution, predominantly prevalent in East Africa and Asia. Despite advances in understanding its ...
Epstein-Barr virus is a common infection that can cause mononucleosis. Learn more about how EBV is linked to an increased risk of nasopharyngeal cancer.
Researchers have discovered a significant association between specific Epstein-Barr virus (EBV) variants and nasopharyngeal carcinoma (NPC). NPC is a cancer notably prevalent in southern China ...
To determine whether screening with EBV-based markers can reduce NPC-specific mortality, the investigators organized a randomized trial involving 16 towns within the larger cities of Sihui and ...
Epigenetics involves a series of biological processes that regulate chromatin-mediated DNA templates. 2 Cancer is a ...